MDY Mdy Healthcare

RNS No 4973v
MEDISYS PLC
30 April 1999

                           MEDISYS PLC
                         ("the Company")

                          AGM STATEMENT

At the Company's Annual General Meeting held today, Bill Bruce, Chairman, made
the following opening remarks:

"Overall, trading in the first six months of the year has been satisfactory.

"Hypoguard, our blood glucose monitoring business, recently reported its highest
sales month in over two years. Good technical progress has been made in the
continuing development and validation of the Arrow reusable blood glucose
monitor. We have entered into discussions with several potential marketing
partners for the Arrow product, in both the pharmaceutical and medical device
sectors, and are confident of a successful outcome in due course. In addition,
Hypoguard has also received a #250,000 DTI grant to help fund development of an
innovative peptic ulcer test.

"The Petit Supreme glucose monitoring system was launched in March 1998. The
system has been well received in the market and is exceeding our sales
expectations.

"During the period Biocure was awarded a #125,000 grant from the DTI for the
further development of its anti-angiogenesis test. Royalty income from TCS
Biogicals Limited has begun.

"During the first half of the year management commenced a re-structuring of the
operations of Lukens Medical Corporation following its acquisition in September
1998. A new management team with a strong healthcare marketing and operations
background has been appointed, bringing a new focus to the development of the
business. Following a careful analysis of product margins we decided to withdraw
from certain market sectors which were not yielding adequate returns. In
addition, we have commenced consolidation of operating facilities with a view to
achieving increased manufacturing efficiencies and reduced costs. As part of
this process, we are discontinuing usage of two manufacturing sub-contractors in
Mexico and we are also closing a distribution operation in Florida. These
operations will shortly be located at the Lukens facility in Albuquerque, New
Mexico.

"NIC, our needle incineration business, has now been fully integrated into the
Lukens operation and we are continuing to focus on achieving inclusion in
healthcare provider safety legislation in the US State of California.

Enquiries:

Medisys PLC                                       (30/04/99) 0171 583 4567      
Kurt Amundson, President &                   (Thereafter) 001 650 327 7900
Chief Operating Officer 

Michael Barry, Chief Financial Officer       (Thereafter) 001 770 271 2795

Square Mile Communications                           
Kevin Smith                                                  0171 583 4567

END

CAGFBFFXKZKXBKQ

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024